PharmagenDrx
  • Home
  • Our Services
    • Online Courses
    • Dose Daily
    • Career Counselling
  • Events
    • Conference
      • Upcoming
      • Past
      • Sponsored
    • Workshop
      • Upcoming
      • Past
      • Sponsored
    • Webinar
      • Upcoming
      • Past
      • Sponsored
  • Others
    • College Dictionary
      • Medical Colleges
      • Dental Colleges
      • Pharmacy colleges
      • Paramedical & Allied Colleges
    • Pharma EduPoint
    • Placement Stories
  • Submit Your Events
  • Contact
July 28, 2025 by admin

TCS calls for a tough restructure : Plans 2% workforce reduction in FY26 Says CEO

TCS calls for a tough restructure : Plans 2% workforce reduction in FY26 Says CEO
July 28, 2025 by admin

TCS calls for a tough restructure : Plans 2% workforce reduction in FY26 Says CEO

PharmaGenDrx News Bureau – 28th July, 2025

“One of the toughest decisions I have had to take as CEO”, Tata Consultancy Services (TCS) CEO K. Krithivasan said in a recent interview. TCS, India’s largest IT services firm is set to implement a measured restructuring of its workforce, in the financial year 2026 (Y26). At present, around 6,13,000 people are employed in the company as of Q1 FY 2026; therefore, about 12,200 people will be laid off as per the source, stating 2% reduction of its total workforce.

The CEO defends this initiative, expressing the need and commitment to being agile and future-ready, focusing on growth and internal mobility. Employees at a significantly primary level remain absolutely guarded from this fundamental shift, as this reduction targets middle and senior management positions. It was emphasised that the entire process of re-structuring would be handled with utmost care, especially to ensure that both clients and affected employees face little to no adversities.

The laid-off employees are said to have been receiving a notice period compensation, three months severance pay, along with outplacement opportunities to ensure a respectful and supportive transition. CEO K. Krithivasan acknowledged the constraints in harmonizing  existing  roles with the ever-evolving  demands of dynamic enterprise priorities.

This organizational realignment follows economic uncertainty and a quest to optimize the marginal profits. This move is now said to fuel the other industries to do the same, following TCS’s footsteps. TCS has also delayed employing the lateral hires who have already received an offer letter in recent months. Along with this, RMG of TCS had announced the New Billability Policy, according to which, an employee must have 225 billable days and only be allowed 35 days of benching, to aim towards more productivity and client satisfaction.

The CEO also added that this step towards re-modelling was initiated to prevent decision-making delays, ensuring the company’s productivity by continuous meaningful project opportunities, professional growth benefits and value-driven recognition.

By Arundhuti Chatterjee & Sharon Bose

LET’S KEEP IN TOUCH!

We’d love to keep you updated with our latest news and offers 😎

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

Previous articleNew Hope for Breast Cancer: Itovebi by Roche gets EU ApprovalNext article GSK GETS EU NOD: BLENREP, A NEW ERA FOR MYLOMA CARE

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About The Blog

Nulla laoreet vestibulum turpis non finibus. Proin interdum a tortor sit amet mollis. Maecenas sollicitudin accumsan enim, ut aliquet risus.

Recent Posts

MoHFW Unveils Clinical Decision Support App to Digitize India’s Frontline HealthcareApril 19, 2026
Pharmacy Students’ Initiative at Hridaypur, Barasat: Bringing Healthcare and Humanity to the UnderservedApril 18, 2026
PCI Unveils NEP-Aligned B.Pharm Curriculum for 2026–27 with Focus on AI and Industry ReadinessApril 17, 2026

Categories

  • Dose daily
  • Event Now
  • Past Webinar
  • Pharma Edupoint
  • Uncategorized
  • Upcoming Workshop

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Tags

Approval Cardiovascular CDSCO Central Compliance Daily news DoP Drug Drug safety Eli Lilly FDA Generic GSK GST GUJARAT healthcare Illegal INDIA Industry Latest news Lupin Medicine Medicines MedTech MoHFW Nationwide Novo Nordisk NPPA Oncology Patient Pharma Pharmacy Prescription Rajasthan Semaglutide Smart SUN PHARMA Treatment UGC US USA USFDA Vaccine WAR WHO

Why Us?

PharmaGenDRx is a platform bridging the gap between education and careers in pharma, lifescience and healthcare. It empowers students and professionals with industry-aligned training, certifications, and real-world skill development.

Contact

Newtown, Chakpachuria, West Bengal 700160
+917908584218
contact@pharmagendrx.com

QUICK LINKS

  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

 

© 2025 PHARMAGENDRX. All Rights are Reserved. Developed & Maintained by XMARTECH

About PharmaGenDRX

PharmaGenDRx is a platform bridging the gap between education and careers in pharma, lifescience and healthcare. It empowers students and professionals with industry-aligned training, certifications, and real-world skill development.

Recent Posts

MoHFW Unveils Clinical Decision Support App to Digitize India’s Frontline HealthcareApril 19, 2026
Pharmacy Students’ Initiative at Hridaypur, Barasat: Bringing Healthcare and Humanity to the UnderservedApril 18, 2026
PCI Unveils NEP-Aligned B.Pharm Curriculum for 2026–27 with Focus on AI and Industry ReadinessApril 17, 2026

Categories

  • Dose daily
  • Event Now
  • Past Webinar
  • Pharma Edupoint
  • Uncategorized
  • Upcoming Workshop